Estimating the pre- and post-diagnosis costs of tuberculosis for adults in Pakistan: household economic impact and costs mitigating strategies.
Adults
Household expenditures
Pakistan
Pre- and post-diagnostic costs
TB care
Journal
Global health research and policy
ISSN: 2397-0642
Titre abrégé: Glob Health Res Policy
Pays: England
ID NLM: 101705789
Informations de publication
Date de publication:
21 07 2022
21 07 2022
Historique:
received:
11
06
2021
accepted:
11
07
2022
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
Despite free tuberculosis (TB) care in Pakistan, patients still have to bear high costs, which push them into poverty. This study estimated the pre- and post-diagnosis costs households bear for TB care, and investigated coping mechanisms among adults ≥ 18 years in Karachi, Pakistan. We conducted a cross-sectional study comprising of 516 TB patients identified with completion of at least one month intensive treatment from four public sector health facilities from two institutes in Karachi, Pakistan. A standardized questionnaire to estimate patient's costs was administered. The study outcomes were direct medical and non-medical costs, and indirect costs. The costs were estimated during pre-diagnostic and post-diagnostic phase which includes diagnostic, treatment, and hospitalization phases. A descriptive analysis including mean and standard deviation (± SD), median and interquartile range (IQR), and frequencies and proportions (%) was employed. Out of 516 TB patients, 52.1% were female with a mean age of 32.4 (± 13.7) years. The median costs per patient during the pre-diagnostic, diagnostic, treatment and hospitalization periods were estimated at USD63.8/ PKR7,377, USD24/ PKR2,755, USD10.5/ PKR1,217, and USD349.0/ PKR40,300, respectively. The total household median cost was estimated at USD129.2/ PKR14,919 per patient. The median indirect cost was estimated at USD52.0/ PKR5,950 per patient. Of total, 54.1% of patients preferred and consulted private providers in the first place at the onset of symptoms, while, 36% attended public healthcare services, 5% and 4.1% went to dispensary and pharmacy, respectively, as a first point of care. TB patients bear substantial out-of-pocket costs before they are enrolled in publically funded TB programs. There should be provision of transport and food vouchers, also health insurance for in-patient treatment. This advocates a critical investigation into an existing financial support network for TB patients in Pakistan towards reducing the burden.
Sections du résumé
BACKGROUND
Despite free tuberculosis (TB) care in Pakistan, patients still have to bear high costs, which push them into poverty. This study estimated the pre- and post-diagnosis costs households bear for TB care, and investigated coping mechanisms among adults ≥ 18 years in Karachi, Pakistan.
METHODS
We conducted a cross-sectional study comprising of 516 TB patients identified with completion of at least one month intensive treatment from four public sector health facilities from two institutes in Karachi, Pakistan. A standardized questionnaire to estimate patient's costs was administered. The study outcomes were direct medical and non-medical costs, and indirect costs. The costs were estimated during pre-diagnostic and post-diagnostic phase which includes diagnostic, treatment, and hospitalization phases. A descriptive analysis including mean and standard deviation (± SD), median and interquartile range (IQR), and frequencies and proportions (%) was employed.
RESULTS
Out of 516 TB patients, 52.1% were female with a mean age of 32.4 (± 13.7) years. The median costs per patient during the pre-diagnostic, diagnostic, treatment and hospitalization periods were estimated at USD63.8/ PKR7,377, USD24/ PKR2,755, USD10.5/ PKR1,217, and USD349.0/ PKR40,300, respectively. The total household median cost was estimated at USD129.2/ PKR14,919 per patient. The median indirect cost was estimated at USD52.0/ PKR5,950 per patient. Of total, 54.1% of patients preferred and consulted private providers in the first place at the onset of symptoms, while, 36% attended public healthcare services, 5% and 4.1% went to dispensary and pharmacy, respectively, as a first point of care.
CONCLUSIONS
TB patients bear substantial out-of-pocket costs before they are enrolled in publically funded TB programs. There should be provision of transport and food vouchers, also health insurance for in-patient treatment. This advocates a critical investigation into an existing financial support network for TB patients in Pakistan towards reducing the burden.
Identifiants
pubmed: 35858877
doi: 10.1186/s41256-022-00259-x
pii: 10.1186/s41256-022-00259-x
pmc: PMC9301862
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
22Informations de copyright
© 2022. The Author(s).
Références
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):802-810
pubmed: 32912385
J Epidemiol Glob Health. 2021 Mar;11(1):83-91
pubmed: 32959604
Int J Tuberc Lung Dis. 2014 Jan;18(1):55-60
pubmed: 24365553
Infect Dis Poverty. 2016 Nov 1;5(1):93
pubmed: 27799063
Int J Tuberc Lung Dis. 2008 Aug;12(8):928-35
pubmed: 18647453
Trop Med Int Health. 2018 Aug;23(8):870-878
pubmed: 29851223
BMJ Open. 2014 Jun 10;4(6):e004818
pubmed: 24916087
Indian J Tuberc. 2022 Oct;69(4):446-452
pubmed: 36460374
Cost Eff Resour Alloc. 2012 May 11;10(1):6
pubmed: 22577948
BMC Public Health. 2010 Mar 30;10:173
pubmed: 20353567
Sci Rep. 2022 Jan 11;12(1):558
pubmed: 35017604
Front Public Health. 2021 Feb 15;9:614466
pubmed: 33659233
PLoS One. 2016 Feb 10;11(2):e0148293
pubmed: 26863617
J Health Popul Nutr. 2018 May 21;37(1):15
pubmed: 29784037
BMC Public Health. 2017 Feb 22;17(1):221
pubmed: 28222724
Lancet Infect Dis. 2018 Mar;18(3):261-284
pubmed: 29223583
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7
pubmed: 23407227
Eur Respir J. 2014 Jun;43(6):1763-75
pubmed: 24525439
BMC Infect Dis. 2020 Jun 29;20(1):456
pubmed: 32600284
PLoS One. 2018 May 9;13(5):e0193293
pubmed: 29742106
Pharmacoecon Open. 2018 Sep;2(3):281-296
pubmed: 29623632
Soc Sci Med. 2021 May;277:113875
pubmed: 33848718
PLoS One. 2013 Aug 27;8(8):e73134
pubmed: 24015293
PLoS One. 2018 May 14;13(5):e0196237
pubmed: 29758022
Int J Tuberc Lung Dis. 2011 Jan;15(1):90-6
pubmed: 21276303
Int J Tuberc Lung Dis. 2013 Dec;17(12):1575-80
pubmed: 24200271